Search

Search Constraints

You searched for: Author/Creator Brosseau, Solenn

Search Results

2. Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial. (August 2021)

3. Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer. (June 2019)

5. EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice. Issue 2 (10th August 2017)

6. Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience. (1st September 2019)

9. Lazarus syndrome in nonsmall cell lung cancer patients with poor performance status and major leukocytosis following nivolumab treatment. Issue 1 (27th July 2017)

10. Management of immune-related adverse events resulting from immune checkpoint blockade. Issue 3 (4th March 2019)